Bremelanotide (PT-141)
Melanocortin agonist discussed for sexual dysfunction indications where approved.
Overview
Mechanism overlaps melanocortin tanning peptides — distinct regulatory context.
What it is
Cyclic heptapeptide melanocortin receptor agonist.
Mechanism (high level)
Central melanocortin pathways modulate sexual response; blood pressure effects matter.
Quick facts
- Dosage
- Per label (subcutaneous autoinjector where approved)
- Route
- Subcutaneous
- Cycle
- As-needed vs chronic per indication
- Storage
- Per manufacturer
Research indications
- Hypoactive sexual desire (where approved)
Research protocols (education)
Education-first logging template
Use PepTok to track adherence and notes; any protocol must be directed by a qualified clinician.
Interactions
Often avoided with
- Uncontrolled hypertension
- nitrates
Often combined with
- Cardiovascular screening when prescribed
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- Nausea, flushing, blood pressure changes — avoid if hypertensive crisis risk.
Regulatory notes
- FDA-approved for specific populations in the US; varies elsewhere.
FAQ
Is this a prescription?
PepTok does not provide prescriptions; it is for logging and education.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.